DE | EN
Book an initial consultation

Services · Analytical Services

Precise GMP analytical testing. Reliable results. Efficient batch release.

Is your own laboratory at full capacity, or is a method you need unavailable or not yet established? Then it is not just the test result that is delayed: batch release can stall too. A&O Pharma takes on your samples in our GMP-certified laboratory. With fully digital workflows, we process your orders efficiently, transparently and traceably, for reliable results and short turnaround times.

Triple-quad LC-MS/MS 8 disciplines

No obligation, in confidence. We reply within one to two working days.

§ 14 AMWHV
GMP-certified analytical laboratory
ICH Q2(R2)
Analytical method validation under current international guidelines
Ultivo 6475
Triple quadrupole LC-MS/MS for trace analysis in the nanogram range

Robust analytical results are the foundation for sound batch decisions and timely release.

The question that matters

What if there is no suitable test method for your product yet?

Then we develop and validate one. For trace analysis and new active substances, this is the norm rather than the exception, which is why method development is a standard part of our services and not a special assignment. We tell you in advance whether development is needed, how long it will take and whether it is more economical than using a specialist laboratory. For traces at nanogram level or below, we use a triple quadrupole LC-MS/MS system.

Our state-of-the-art, fully digitalised GMP laboratory processes your samples quickly and efficiently. You receive test results from one provider, documented to GMP standards and ready for inspection. Every assessment is made under the responsibility of the Head of Quality Control and, where batch release is involved, also under the responsibility of a Qualified Person under § 14 AMG.

Release testing and EU retesting of finished medicinal products

To ensure quality and safety, we carry out complete testing to your product specification, including batch release. Our services include:

  • Spectroscopy: IR spectroscopy for identification, UV-VIS spectroscopy.
  • Chromatography: thin-layer chromatography (identity and purity); gas chromatography for assay, purity and residual solvents, with FID detection, headspace and direct injection; liquid chromatography (HPLC, HPLC-MS/MS) for assay, related substances, enantiomeric purity and identity, with DAD and MS/MS detection.
  • Physicochemical testing: clarity and opalescence, colour of liquids, pH, relative density, loss on drying, water content by Karl Fischer titration, ethanol content, methanol and 2-propanol.
  • Testing of solid dosage forms: dissolution testing (on-line and off-line, paddle and basket apparatus), disintegration of tablets and capsules, tablet hardness, uniformity of content and uniformity of mass of single-dose preparations.
  • Other tests: extractable volume of parenteral preparations, microscopy.

Your method is not listed? Please get in touch. Many other tests are carried out in cooperation with carefully selected, qualified partner laboratories.

Testing of starting materials using pharmacopoeial methods

Quality control of raw and starting materials, excipients and active substances. Testing for identity, assay and purity according to the common national and international monographs (Ph. Eur., USP) or your own specifications.

Testing of cannabis flos and cannabis extracts

We test medicinal cannabis flowers and extracts in our GMP laboratory using validated methods, providing a reliable basis for entering the German and European markets. Testing covers both the German and the European Pharmacopoeia.

  • Cannabis flowers in accordance with Ph. Eur. 07/2024:3028 (Cannabis flos) and Ph. Eur. 07/2017:1433 (Herbal drugs): macroscopic and microscopic identification and identification by TLC (Ph. Eur. 2.8.25); assay of the cannabinoids THC, THC-A, CBD and CBD-A by HPLC (Ph. Eur. 2.2.29); tests for cannabinol, foreign matter (Ph. Eur. 2.8.2) and loss on drying (Ph. Eur. 2.2.32); determination of total ash (Ph. Eur. 2.4.16).
  • Cannabis extracts in accordance with the German Pharmacopoeia (DAB, standardised cannabis extract) and Ph. Eur. 04/2019:0765 (Herbal drug extracts): identification by TLC (Ph. Eur. 2.2.27), THC and CBD content by HPLC, purity tests including water content (Ph. Eur. 2.5.12), residual solvents such as ethanol (Ph. Eur. 5.4) and relative density (Ph. Eur. 2.2.5).
  • Contaminants and microbiology: aflatoxins B1, B2, G1 and G2 (Ph. Eur. 2.8.18), ochratoxin A (Ph. Eur. 2.8.22), pesticides and dithiocarbamates (Ph. Eur. 2.8.13), the heavy metals arsenic, lead, cadmium and mercury (Ph. Eur. 2.4.27), and microbiological quality testing according to Ph. Eur. 5.1.8, categories A, B and C, and Ph. Eur. 5.1.4.

Biotechnological medicinal products

Testing of proteins, peptides including synthetic and recombinant peptides, oligonucleotides and mRNA. Assay and purity testing, molecular mass determination and determination of degradation products by HPLC-MS/MS (quadrupole). Purity by RP-HPLC or SEC-HPLC.

Trace analysis, method development, stability and microbiology

  • Trace analysis by LC-MS/MS: triple quadrupole system for nitrosamines in the sub-nanogram range, the basis of every robust nitrosamine risk assessment.
  • Method development: development, validation and transfer of analytical methods under GMP conditions.
  • Stability testing: long-term, accelerated and in-use studies in line with ICH guidelines.
  • Microbiological testing: microbial enumeration, sterility testing and bacterial endotoxins.

Process

From enquiry to certificate of analysis.

4 steps, one dedicated contact, no surprises.

Book an initial consultation
01

Defining the method

We review the specification and check whether a method exists. If not, we develop and validate one, or implement your existing method.

02

Sending the sample

We tell you the quantity, packaging and shipping route. Sample receipt is documented in line with GMP.

03

Testing in the laboratory

Performed in our GMP-compliant laboratory and fully recorded in the laboratory information system.

04

Assessed result

You receive the certificate of analysis with a technical assessment, for which the Head of Quality Control is responsible.

Typical starting points

Does one of these sound familiar?

Your own laboratory at its limit

Your laboratory capacity is fully booked, and your batch is still waiting for release. What you need is not more laboratory space but extra capacity for this batch.

Method not available in-house

A test requires specialised analytical methods and in-depth expertise that you do not want to maintain permanently, for example demanding trace analysis in the sub-nanogram range.

Imports from third countries

For products from outside the EEA from a country without a mutual recognition agreement (MRA), EU retesting is mandatory before the Qualified Person may certify the batch.

Suspected nitrosamine contamination

You need a sound risk assessment and, where necessary, analytical confirmation at concentrations that many laboratories cannot reliably measure.

Measuring range

Down to the last order of magnitude

Six orders of magnitude separate the active substance content of a tablet from potential nitrosamine levels. A laboratory that can only cover the upper concentration range cannot fully support a robust nitrosamine assessment. Our triple quadrupole system reaches down to the lowest relevant concentration ranges, so we can confirm results analytically exactly where it matters.

g Gram Starting materials and formulation quantities
mg Milligram Active substance content of a tablet
µg Microgram Elemental impurities: permitted daily exposure (PDE) under ICH Q3D
ng Nanogram Nitrosamines: acceptable intake (AI) limits set by EMA

Our measuring range covers the full spectrum

Triple quadrupole LC-MS/MS for nitrosamines and aflatoxins down to the nanogram range, in our own GMP-certified laboratory in Itzehoe. This gives us the analytical basis for robust nitrosamine risk assessments, and we carry out critical tests in-house without relying on an external laboratory.

Responsibility

Who is responsible for our analytical testing.

You know from the start who will handle your project: name, position and direct phone number. Before the contract starts, not afterwards. Not an anonymous team, but one specific contact.

Dr. Thomas Lutz

Dr. Thomas Lutz

Qualified Person (QP) and Head of Production

QP

Key areas

  • Qualified Person under § 14 AMG
  • Head of Production under the AMWHV
  • Responsible person for wholesale distribution of medicinal products under § 52a AMG
  • Stufenplanbeauftragter under § 19(7) AMWHV

Degree in pharmacy, licence to practise as a pharmacist, doctorate in pharmaceutical chemistry

Dr. Kai Huwig

Dr. Kai Huwig

Qualified Person (QP) and Head of Quality Control

QP

Key areas

  • Qualified Person under § 14 AMG
  • Validation of analytical methods
  • Head of Quality Control under the AMWHV

Degree and doctorate in chemistry, postgraduate pharmacy programme to acquire the expert knowledge required under § 15 AMG

Dr. Emmanuel Bey

Dr. Emmanuel Bey

Analytical Development

QP

Key areas

  • Analytical development, including validation and transfer of analytical methods
  • IMPD and dossier preparation

Doctorate in pharmaceutical chemistry

Dr. Olaf Mundszinger

Dr. Olaf Mundszinger

Founder and Managing Director

QP

Key areas

  • Pharmaceutical quality control and quality assurance
  • Narcotics Officer
  • IMPD preparation
  • Pharmaceutical analysis

Doctorate in analytical chemistry, degree in pharmaceutical sciences and chemistry

Dr. Anne Katharina Schmidt

Dr. Anne Katharina Schmidt

Head of Quality Control

Key areas

  • Quality control
  • Pharmaceutical analysis
  • Validation, verification and transfer of methods
  • Evaluation and release of analytical results

Degree in chemistry followed by a doctorate in supramolecular chemistry.

Case studies

Problems we have solved in this area.

Anonymised projects from this service: starting point, approach and outcome.

Frequently asked questions about our analytical services.

We will answer your questions in an initial consultation. Dr. Thomas Lutz will take the time to go through them with you.

Book an initial consultation
Which analytical methods do you have in-house?

Our analytical services cover eight core disciplines: release testing and EU retesting to product specification, including IR, UV-VIS, thin-layer chromatography, GC-FID, HPLC, HPLC-MS/MS, loss on drying/water content, dissolution, disintegration/tablet hardness and microscopy; raw material testing to Ph. Eur. and USP; testing of herbal medicinal products such as cannabis flos, including cannabis extracts; testing of biotechnological medicinal products such as proteins, peptides, oligonucleotides and mRNA; GMP-compliant method development and validation; trace analysis by LC-MS/MS; stability testing in line with ICH; and microbiological testing. Not sure whether your analytical question is covered? Please get in touch and we will work out together how we can support you.

Is the laboratory GMP-certified?

Yes. Our analytical laboratory is GMP-certified. This provides a reliable basis for the assessment and documentation of analytical results.

How low can your trace analysis go for nitrosamines and aflatoxins?

For trace analysis, we use an Agilent Ultivo 6475 triple quadrupole. This allows us to detect nitrosamines and other (geno)toxic impurities down to the sub-nanogram range, the sensitivity usually needed to ensure a medicinal product is safe. The methods are validated under GMP.

Can you also analyse biotechnological medicinal products?

Yes. We analyse proteins, peptides, oligonucleotides and mRNA by HPLC-MS/MS using quadrupole technology. Many clients do not have these methods in-house, so we provide them as a specialised service.

What if the method you need does not exist yet?

Then we develop it. Method development, validation and transfer under GMP are part of our services. This gives you a validated test method that will stand up to regulatory scrutiny, even for new or demanding questions, without having to maintain your own equipment or staff. The know-how gained is available to you.

Who is responsible for the results?

Our Head of Quality Control is responsible for the analytical results. This gives you a personal contact with clearly defined statutory responsibility. Our analytical contacts are based at our Itzehoe site.

Services that are often used together

Tell us about your project.

Call us or write a few lines. You will reach someone who can assess your request with real expertise.

Life Science Nord

As a member of the Life Science Nord cluster, we benefit from a strong, innovative network and work with other experts in the industry on forward-looking developments.

Scientist.com Registered Supplier

As a registered supplier on Scientist.com, we can also be reached through this platform: companies registered there can send their project requests directly to us.